Related Experiment Video
Updated: Mar 30, 2026
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
Source of care and variation in long-acting reversible contraception use
Lauren Groskaufmanis1, Saba W Masho1
1Department of Family Medicine and Population Health, Division of Epidemiology, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
Objective:
To examine variation in long acting reversible contraception (LARC) use by source of birth control services.
Design:
Cross-sectional study.
Setting:
Not applicable.
Patient(S):
Sexually active women who received contraceptive services in the past 12 months, who were neither pregnant nor trying to become pregnant and who were not sterilized and nor were their partners sterilized.
Intervention(S):
Three multinomial logistic regression models assessed the relationship between source of services and LARC use, controlling for covariates. The odds of LARC use were compared with LARC nonuse, high-efficacy use, and low-efficacy use.
Main Outcome Measure(S):
Reported LARC method use.
Result(S):
There was no statistically significant difference in LARC use between women receiving services from community or public health clinics and women receiving services from private clinics. Women receiving care at a family-planning clinics had lower odds of LARC use versus LARC nonuse (odds ratio [OR] = 0.27; 95% confidence interval [CI], 0.10-0.74), versus high-efficacy method use (OR = 0.32; 95% CI, 0.11-0.88) and versus low-efficacy method use (OR = 0.13; 95% CI, 0.02-0.87) compared with those receiving services at private clinics.
Conclusion(S):
Women receiving care from family-planning clinics had lower odds of LARC use compared with those receiving care from a private doctor's office or health maintenance organization facility.
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
01:22Birth Control Methods
01:26Oral Drug Delivery Systems: Continuous-Release Systems
01:22Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...